Article Text

other Versions

Download PDFPDF
Case series
Ophthalmic artery occlusion after Pipeline Embolization Device placement with reconstitution of flow via an endoleak: a report of two cases
  1. Michael L Adix,
  2. Ian A Kaminsky,
  3. In Sup Choi
  1. Department of Interventional Neuroradiology, Lahey Hospital and Medical Center Burlington, Burlington, Massachusetts, USA
  1. Correspondence to Dr Michael L Adix, Department of Interventional Neuroradiology, Lahey Hospital and Medical Center Burlington, Burlington, MA 01805, USA; bukagod{at}me.com

Abstract

The Pipeline Embolization Device (PED) is a flow diverting stent used in the treatment of a wide variety of intracranial aneurysms. The device differs from traditional stents used in stent-assisted coil embolization in that it has a tighter lattice structure with smaller cell sizes designed specifically to disrupt blood flow into aneurysms rather than only to retain coils within aneurysms. While the PED has been shown to be safe and effective, it has a unique risk profile that includes side branch and perforator vessel occlusion. Side branch occlusion in particular has been noted in several articles to occur at a relatively high rate with coverage of the ophthalmic artery origin by the PED. In this series, we present two cases of ophthalmic artery occlusion after PED placement with reconstitution of flow via an endoleak.

  • Aneurysm
  • Complication
  • Flow Diverter
  • Stent
  • Angiography

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement All additional patient data are part of the patients' electronic medical records.